CClinicalTrials.gg
CompletedNCT01942057FalconUpdated Jul 20, 2015

Myopia Prevalence in Canadian School Children - a Pilot Study

An observational study in Myopia, sponsored by University of Waterloo. Completed at 1 site in Canada. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-07-20.

Sponsored by University of Waterloo · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
173
Ages
6 Years to 18 Years
Sex
All
01

Study summary

The goal of this study is to determine the prevalence of nearsightedness in Canadian school children living in the Waterloo Region.

02

Conditions studied

  • Myopia

Browse trials for

03

In context

Myopia

984 studies on the registry are indexed under Myopia; 210 are open to participants now.

This study's enrollment of 173 is above the median of 150 across 173 observational studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

University of Waterloo is the lead sponsor of 90 studies on the registry; 8 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 9 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

School children in Waterloo Region

Inclusion criteria

  • Has had a parent/legal guardian read the study consent form and who agrees to allow them to participate in the study by signing the consent form
  • Has had the "letter of assent for children" explained to them, the child has agreed to participate and the letter has been signed by the study investigator and the child
  • Has provided the completed Questionnaire (Appendix 4A for parents to complete on behalf of their children in school grades 1 and 2, 6 and 7; Appendix 4B for children to complete that are in school grades 11 and 12)
  • Is currently in school grades 1 and 2, 6 and 7 or 11 and 12
  • Is willing and able to follow instructions and maintain the appointment schedule

Exclusion criteria

Exclusion Criteria:

  • Has not given verbal assent to participate
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
  • Has undergone refractive error surgery or orthokeratology
  • Has serious medical disorders or eye diseases/abnormalities such as amblyopia and cataract or a cognitive inability to conduct the tests
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
173 participants (actual)
Patient registry
No

Groups and cohorts

  • School Grades 1+2

    Children currently enrolled in grades 1 and 2

  • School Grades 6+7

    Children currently enrolled in grades 6 and 7

  • School Grades 11+12

    Children currently enrolled in grades 11 and 12

06

What researchers measure

Primary outcomes

  1. Number of children with spherical equivalent refraction of at least -0.50D in at least one eye

    Time frame: Day1

07

Study locations

1 site
  • Centre for Contact Lens Research
    Waterloo, Ontario N2L3G1, Canada
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01942057
Lead sponsor
University of Waterloo
Responsible party
Sponsor
First posted
Sep 13, 2013
Start date
Dec 2013
Primary completion
Apr 2015
Completion
Apr 2015
Last update
Jul 20, 2015

Study contacts

Lyndon Jones, PhD
principal investigator · Center for Contact Lens Research

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion